Status:
AVAILABLE
Expanded Access for Apixaban
Lead Sponsor:
Bristol-Myers Squibb
Eligibility:
All Genders
28-17 years
Brief Summary
This is an expanded access designed to provide access to apixaban for eligible participants.
Eligibility Criteria
Inclusion
- Pediatric patients with Congenital or Acquired Heart Disease Requiring Chronic Anticoagulation for Thromboembolism Prevention
- Previously participated in the CV185-362 study and was on apixaban for 1 year or until treatment was no longer required
Exclusion
- Weight less than 5 kg or greater than 35 kg
- Other inclusion/exclusion criteria apply
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05187286
Last Update
March 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hospital Of Philadelphia
Philadelphia, Pennsylvania, United States, 19104